Genomics in Cancer Care Market Report, Analysis, Opportunities by 2031
The Genomics in Cancer Care Market is expected to register a CAGR of 15.8% from 2024 to 2031, with a market size expanding from US$ XX million in 2024 to US$ XX Million by 2031.
The Genomics in Cancer Care Market report covers analysis By Product and Service (Instruments, Consumables, Software and Service); Technology (Gene Sequencing, PCR, Microarray Nucleic Acid Extraction and Purification, Others); Application (Diagnostic, Drug Delivery, Precision Medicine, Research); End User (Hospitals, Diagnostics Laboratories, Academic and Research Institutes). The global analysis is further broken-down at regional level and major countries. The Report Offers the Value in USD for the above analysis and segments.
Purpose of the ReportThe report Genomics in Cancer Care Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:
- Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
- Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
- Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.
Genomics in Cancer Care Market Segmentation
Product and Service- Instruments
- Consumables
- Software and Service
- Gene Sequencing
- PCR
- Microarray Nucleic Acid Extraction and Purification
- Diagnostic
- Drug Delivery
- Precision Medicine
- Research
- Hospitals
- Diagnostics Laboratories
- Academic and Research Institutes
Strategic Insights
Genomics in Cancer Care Market Growth Drivers- Increased Incidence of Cancer Cases: Enhanced global cancer cases grow demand in genomics-based personalized therapies, which, in turn, boosts market size growth. Market studies reveal genomic data as the spine of treatment and outcome optimization.
- The Genomic Technologies Breakthrough: NGS and CRISPR-based technologies continue to fuel market growth. The analysis for competitive scenario stresses precision oncology and diagnostics application, which continues to soar high.
- Government and Private Investments: Funds set aside for cancer genomics research enable the market to be supported by the current market trends thereby having an enthusiastic innovation ecosystem. PEST analysis shows increased collaboration in developing complete care solutions to enhance the global market.
- Emerging Technologies in Genomic Medicine: Genomics-based precision therapies give new dimensions to cancer care through treatment tailoring. The need for personalized medicine increases and key players are innovating genomic testing and data analytics solutions.
- Increasing Adoption of Liquid Biopsies: Liquid biopsies, which use blood samples to detect genetic mutations and cancer biomarkers, are becoming more common in oncology. These minimally invasive tests are expected to increase patient compliance and diagnostic accuracy. The adoption of liquid biopsy technology is a key growth driver in the genomic testing market, particularly for early cancer detection and monitoring treatment effectiveness.
- Global Expansion of Genomic Databases: The growth of genomic databases and biobanks globally is enabling the identification of new genetic mutations associated with various cancers. This helps tailor precision therapies and allows for improved treatment outcomes. Expanding access to large-scale genomic data from diverse populations is enhancing the development of personalized treatments, thus further boosting the genomic testing market.
- Expansion of Personalized Oncology: The market overview manifests growth with regard to Precision Medicine since it takes genomics to the next level of cancers that have treatment differences. It leads with geographical stronghold by North America through market shares concerning genomics-based therapies since it not only indicates growth beyond market share but also improves care.
- Next-Generation Sequencing: The most prominent prospect for Next-Generation Sequencing is the ability to have a broad breadth of sequencing capabilities due to its higher output at much lower costs. Early detection and targeted selection of therapy have led to a supporting industry.
- Government Support and Research Funding: As precision medicine and genomic therapies continue to show promise in treating various forms of cancer, government funding and support for research and development in genomics are increasing. Initiatives and grants aimed at advancing genomic medicine and enhancing healthcare systems contribute significantly to the market's growth. This support is particularly noticeable in regions like North America and Europe, where governments are increasingly prioritizing healthcare innovation.
Market Report Scope
Key Selling Points
- Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Genomics in Cancer Care Market, providing a holistic landscape.
- Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
- Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
- Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.
The research report on the Genomics in Cancer Care Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Some of the customization options available based on request are additional 3-5 company profiles and country-specific analysis of 3-5 countries of your choice. Customizations are to be requested/discussed before making final order confirmation, as our team would review the same and check the feasibility.
The report can be delivered in PDF/PPT format; we can also share excel dataset based on the request.
Key companies of this market are: Illumina Inc., Agilent Technologies, Inc., Thermo Fisher Scientific Inc., PerkinElmer, Inc., QIAGEN, Abbott, BGI, F. Hoffmann La Roche AG, Bio Rad Laboratories, Inc.
Key future trends in this market are - Precision Medicine Advancements, Integration of AI and Big Data, Rising Cancer Prevalence
The Genomics in Cancer Care Market is estimated to witness a CAGR of 15.8% from 2023 to 2031.
The major factors driving the market are: Rising global cancer rates, Breakthroughs in genomic technologies, Increased government and private funding
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Genomics In Cancer Care Market - By Product and Service
1.3.2 Genomics In Cancer Care Market - By Technology
1.3.3 Genomics In Cancer Care Market - By Application
1.3.4 Genomics In Cancer Care Market - By End User
1.3.5 Genomics In Cancer Care Market - By Region
1.3.5.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. GENOMICS IN CANCER CARE MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PORTER'S FIVE FORCES ANALYSIS
4.2.1 Bargaining Power of Buyers
4.2.1 Bargaining Power of Suppliers
4.2.1 Threat of Substitute
4.2.1 Threat of New Entrants
4.2.1 Competitive Rivalry
4.3. EXPERT OPINIONS
5. GENOMICS IN CANCER CARE MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. GENOMICS IN CANCER CARE MARKET - GLOBAL MARKET ANALYSIS
6.1. GENOMICS IN CANCER CARE - GLOBAL MARKET OVERVIEW
6.2. GENOMICS IN CANCER CARE - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. GENOMICS IN CANCER CARE MARKET - REVENUE AND FORECASTS TO 2028 - PRODUCT AND SERVICE
7.1. OVERVIEW
7.2. PRODUCT AND SERVICE MARKET FORECASTS AND ANALYSIS
7.3. INSTRUMENTS
7.3.1. Overview
7.3.2. Instruments Market Forecast and Analysis
7.4. CONSUMABLES
7.4.1. Overview
7.4.2. Consumables Market Forecast and Analysis
7.5. SOFTWARE AND SERVICE
7.5.1. Overview
7.5.2. Software and Service Market Forecast and Analysis
8. GENOMICS IN CANCER CARE MARKET - REVENUE AND FORECASTS TO 2028 - TECHNOLOGY
8.1. OVERVIEW
8.2. TECHNOLOGY MARKET FORECASTS AND ANALYSIS
8.3. GENE SEQUENCING
8.3.1. Overview
8.3.2. Gene Sequencing Market Forecast and Analysis
8.4. PCR
8.4.1. Overview
8.4.2. PCR Market Forecast and Analysis
8.5. MICROARRAY NUCLEIC ACID EXTRACTION AND PURIFICATION
8.5.1. Overview
8.5.2. Microarray Nucleic Acid Extraction and Purification Market Forecast and Analysis
8.6. OTHERS
8.6.1. Overview
8.6.2. Others Market Forecast and Analysis
9. GENOMICS IN CANCER CARE MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
9.1. OVERVIEW
9.2. APPLICATION MARKET FORECASTS AND ANALYSIS
9.3. DIAGNOSTIC
9.3.1. Overview
9.3.2. Diagnostic Market Forecast and Analysis
9.4. DRUG DELIVERY
9.4.1. Overview
9.4.2. Drug Delivery Market Forecast and Analysis
9.5. PRECISION MEDICINE
9.5.1. Overview
9.5.2. Precision Medicine Market Forecast and Analysis
9.6. RESEARCH
9.6.1. Overview
9.6.2. Research Market Forecast and Analysis
10. GENOMICS IN CANCER CARE MARKET - REVENUE AND FORECASTS TO 2028 - END USER
10.1. OVERVIEW
10.2. END USER MARKET FORECASTS AND ANALYSIS
10.3. HOSPITALS
10.3.1. Overview
10.3.2. Hospitals Market Forecast and Analysis
10.4. DIAGNOSTICS LABORATORIES
10.4.1. Overview
10.4.2. Diagnostics Laboratories Market Forecast and Analysis
10.5. ACADEMIC AND RESEARCH INSTITUTES
10.5.1. Overview
10.5.2. Academic and Research Institutes Market Forecast and Analysis
11. GENOMICS IN CANCER CARE MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
11.1. NORTH AMERICA
11.1.1 North America Genomics In Cancer Care Market Overview
11.1.2 North America Genomics In Cancer Care Market Forecasts and Analysis
11.1.3 North America Genomics In Cancer Care Market Forecasts and Analysis - By Product and Service
11.1.4 North America Genomics In Cancer Care Market Forecasts and Analysis - By Technology
11.1.5 North America Genomics In Cancer Care Market Forecasts and Analysis - By Application
11.1.6 North America Genomics In Cancer Care Market Forecasts and Analysis - By End User
11.1.7 North America Genomics In Cancer Care Market Forecasts and Analysis - By Countries
11.1.7.1 United States Genomics In Cancer Care Market
11.1.7.1.1 United States Genomics In Cancer Care Market by Product and Service
11.1.7.1.2 United States Genomics In Cancer Care Market by Technology
11.1.7.1.3 United States Genomics In Cancer Care Market by Application
11.1.7.1.4 United States Genomics In Cancer Care Market by End User
11.1.7.2 Canada Genomics In Cancer Care Market
11.1.7.2.1 Canada Genomics In Cancer Care Market by Product and Service
11.1.7.2.2 Canada Genomics In Cancer Care Market by Technology
11.1.7.2.3 Canada Genomics In Cancer Care Market by Application
11.1.7.2.4 Canada Genomics In Cancer Care Market by End User
11.1.7.3 Mexico Genomics In Cancer Care Market
11.1.7.3.1 Mexico Genomics In Cancer Care Market by Product and Service
11.1.7.3.2 Mexico Genomics In Cancer Care Market by Technology
11.1.7.3.3 Mexico Genomics In Cancer Care Market by Application
11.1.7.3.4 Mexico Genomics In Cancer Care Market by End User
11.2. EUROPE
11.2.1 Europe Genomics In Cancer Care Market Overview
11.2.2 Europe Genomics In Cancer Care Market Forecasts and Analysis
11.2.3 Europe Genomics In Cancer Care Market Forecasts and Analysis - By Product and Service
11.2.4 Europe Genomics In Cancer Care Market Forecasts and Analysis - By Technology
11.2.5 Europe Genomics In Cancer Care Market Forecasts and Analysis - By Application
11.2.6 Europe Genomics In Cancer Care Market Forecasts and Analysis - By End User
11.2.7 Europe Genomics In Cancer Care Market Forecasts and Analysis - By Countries
11.2.7.1 Germany Genomics In Cancer Care Market
11.2.7.1.1 Germany Genomics In Cancer Care Market by Product and Service
11.2.7.1.2 Germany Genomics In Cancer Care Market by Technology
11.2.7.1.3 Germany Genomics In Cancer Care Market by Application
11.2.7.1.4 Germany Genomics In Cancer Care Market by End User
11.2.7.2 France Genomics In Cancer Care Market
11.2.7.2.1 France Genomics In Cancer Care Market by Product and Service
11.2.7.2.2 France Genomics In Cancer Care Market by Technology
11.2.7.2.3 France Genomics In Cancer Care Market by Application
11.2.7.2.4 France Genomics In Cancer Care Market by End User
11.2.7.3 Italy Genomics In Cancer Care Market
11.2.7.3.1 Italy Genomics In Cancer Care Market by Product and Service
11.2.7.3.2 Italy Genomics In Cancer Care Market by Technology
11.2.7.3.3 Italy Genomics In Cancer Care Market by Application
11.2.7.3.4 Italy Genomics In Cancer Care Market by End User
11.2.7.4 Spain Genomics In Cancer Care Market
11.2.7.4.1 Spain Genomics In Cancer Care Market by Product and Service
11.2.7.4.2 Spain Genomics In Cancer Care Market by Technology
11.2.7.4.3 Spain Genomics In Cancer Care Market by Application
11.2.7.4.4 Spain Genomics In Cancer Care Market by End User
11.2.7.5 United Kingdom Genomics In Cancer Care Market
11.2.7.5.1 United Kingdom Genomics In Cancer Care Market by Product and Service
11.2.7.5.2 United Kingdom Genomics In Cancer Care Market by Technology
11.2.7.5.3 United Kingdom Genomics In Cancer Care Market by Application
11.2.7.5.4 United Kingdom Genomics In Cancer Care Market by End User
11.2.7.6 Rest of Europe Genomics In Cancer Care Market
11.2.7.6.1 Rest of Europe Genomics In Cancer Care Market by Product and Service
11.2.7.6.2 Rest of Europe Genomics In Cancer Care Market by Technology
11.2.7.6.3 Rest of Europe Genomics In Cancer Care Market by Application
11.2.7.6.4 Rest of Europe Genomics In Cancer Care Market by End User
11.3. ASIA-PACIFIC
11.3.1 Asia-Pacific Genomics In Cancer Care Market Overview
11.3.2 Asia-Pacific Genomics In Cancer Care Market Forecasts and Analysis
11.3.3 Asia-Pacific Genomics In Cancer Care Market Forecasts and Analysis - By Product and Service
11.3.4 Asia-Pacific Genomics In Cancer Care Market Forecasts and Analysis - By Technology
11.3.5 Asia-Pacific Genomics In Cancer Care Market Forecasts and Analysis - By Application
11.3.6 Asia-Pacific Genomics In Cancer Care Market Forecasts and Analysis - By End User
11.3.7 Asia-Pacific Genomics In Cancer Care Market Forecasts and Analysis - By Countries
11.3.7.1 Australia Genomics In Cancer Care Market
11.3.7.1.1 Australia Genomics In Cancer Care Market by Product and Service
11.3.7.1.2 Australia Genomics In Cancer Care Market by Technology
11.3.7.1.3 Australia Genomics In Cancer Care Market by Application
11.3.7.1.4 Australia Genomics In Cancer Care Market by End User
11.3.7.2 China Genomics In Cancer Care Market
11.3.7.2.1 China Genomics In Cancer Care Market by Product and Service
11.3.7.2.2 China Genomics In Cancer Care Market by Technology
11.3.7.2.3 China Genomics In Cancer Care Market by Application
11.3.7.2.4 China Genomics In Cancer Care Market by End User
11.3.7.3 India Genomics In Cancer Care Market
11.3.7.3.1 India Genomics In Cancer Care Market by Product and Service
11.3.7.3.2 India Genomics In Cancer Care Market by Technology
11.3.7.3.3 India Genomics In Cancer Care Market by Application
11.3.7.3.4 India Genomics In Cancer Care Market by End User
11.3.7.4 Japan Genomics In Cancer Care Market
11.3.7.4.1 Japan Genomics In Cancer Care Market by Product and Service
11.3.7.4.2 Japan Genomics In Cancer Care Market by Technology
11.3.7.4.3 Japan Genomics In Cancer Care Market by Application
11.3.7.4.4 Japan Genomics In Cancer Care Market by End User
11.3.7.5 South Korea Genomics In Cancer Care Market
11.3.7.5.1 South Korea Genomics In Cancer Care Market by Product and Service
11.3.7.5.2 South Korea Genomics In Cancer Care Market by Technology
11.3.7.5.3 South Korea Genomics In Cancer Care Market by Application
11.3.7.5.4 South Korea Genomics In Cancer Care Market by End User
11.3.7.6 Rest of Asia-Pacific Genomics In Cancer Care Market
11.3.7.6.1 Rest of Asia-Pacific Genomics In Cancer Care Market by Product and Service
11.3.7.6.2 Rest of Asia-Pacific Genomics In Cancer Care Market by Technology
11.3.7.6.3 Rest of Asia-Pacific Genomics In Cancer Care Market by Application
11.3.7.6.4 Rest of Asia-Pacific Genomics In Cancer Care Market by End User
11.4. MIDDLE EAST AND AFRICA
11.4.1 Middle East and Africa Genomics In Cancer Care Market Overview
11.4.2 Middle East and Africa Genomics In Cancer Care Market Forecasts and Analysis
11.4.3 Middle East and Africa Genomics In Cancer Care Market Forecasts and Analysis - By Product and Service
11.4.4 Middle East and Africa Genomics In Cancer Care Market Forecasts and Analysis - By Technology
11.4.5 Middle East and Africa Genomics In Cancer Care Market Forecasts and Analysis - By Application
11.4.6 Middle East and Africa Genomics In Cancer Care Market Forecasts and Analysis - By End User
11.4.7 Middle East and Africa Genomics In Cancer Care Market Forecasts and Analysis - By Countries
11.4.7.1 South Africa Genomics In Cancer Care Market
11.4.7.1.1 South Africa Genomics In Cancer Care Market by Product and Service
11.4.7.1.2 South Africa Genomics In Cancer Care Market by Technology
11.4.7.1.3 South Africa Genomics In Cancer Care Market by Application
11.4.7.1.4 South Africa Genomics In Cancer Care Market by End User
11.4.7.2 Saudi Arabia Genomics In Cancer Care Market
11.4.7.2.1 Saudi Arabia Genomics In Cancer Care Market by Product and Service
11.4.7.2.2 Saudi Arabia Genomics In Cancer Care Market by Technology
11.4.7.2.3 Saudi Arabia Genomics In Cancer Care Market by Application
11.4.7.2.4 Saudi Arabia Genomics In Cancer Care Market by End User
11.4.7.3 U.A.E Genomics In Cancer Care Market
11.4.7.3.1 U.A.E Genomics In Cancer Care Market by Product and Service
11.4.7.3.2 U.A.E Genomics In Cancer Care Market by Technology
11.4.7.3.3 U.A.E Genomics In Cancer Care Market by Application
11.4.7.3.4 U.A.E Genomics In Cancer Care Market by End User
11.4.7.4 Rest of Middle East and Africa Genomics In Cancer Care Market
11.4.7.4.1 Rest of Middle East and Africa Genomics In Cancer Care Market by Product and Service
11.4.7.4.2 Rest of Middle East and Africa Genomics In Cancer Care Market by Technology
11.4.7.4.3 Rest of Middle East and Africa Genomics In Cancer Care Market by Application
11.4.7.4.4 Rest of Middle East and Africa Genomics In Cancer Care Market by End User
11.5. SOUTH AND CENTRAL AMERICA
11.5.1 South and Central America Genomics In Cancer Care Market Overview
11.5.2 South and Central America Genomics In Cancer Care Market Forecasts and Analysis
11.5.3 South and Central America Genomics In Cancer Care Market Forecasts and Analysis - By Product and Service
11.5.4 South and Central America Genomics In Cancer Care Market Forecasts and Analysis - By Technology
11.5.5 South and Central America Genomics In Cancer Care Market Forecasts and Analysis - By Application
11.5.6 South and Central America Genomics In Cancer Care Market Forecasts and Analysis - By End User
11.5.7 South and Central America Genomics In Cancer Care Market Forecasts and Analysis - By Countries
11.5.7.1 Brazil Genomics In Cancer Care Market
11.5.7.1.1 Brazil Genomics In Cancer Care Market by Product and Service
11.5.7.1.2 Brazil Genomics In Cancer Care Market by Technology
11.5.7.1.3 Brazil Genomics In Cancer Care Market by Application
11.5.7.1.4 Brazil Genomics In Cancer Care Market by End User
11.5.7.2 Argentina Genomics In Cancer Care Market
11.5.7.2.1 Argentina Genomics In Cancer Care Market by Product and Service
11.5.7.2.2 Argentina Genomics In Cancer Care Market by Technology
11.5.7.2.3 Argentina Genomics In Cancer Care Market by Application
11.5.7.2.4 Argentina Genomics In Cancer Care Market by End User
11.5.7.3 Rest of South and Central America Genomics In Cancer Care Market
11.5.7.3.1 Rest of South and Central America Genomics In Cancer Care Market by Product and Service
11.5.7.3.2 Rest of South and Central America Genomics In Cancer Care Market by Technology
11.5.7.3.3 Rest of South and Central America Genomics In Cancer Care Market by Application
11.5.7.3.4 Rest of South and Central America Genomics In Cancer Care Market by End User
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. GENOMICS IN CANCER CARE MARKET, KEY COMPANY PROFILES
13.1. ILLUMINA INC.
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. AGILENT TECHNOLOGIES, INC.
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. THERMO FISHER SCIENTIFIC INC.
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. PERKINELMER, INC.
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. QIAGEN
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. ABBOTT
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. BGI
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. F. HOFFMANN LA ROCHE AG
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. BIO RAD LABORATORIES, INC.
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. BECKMAN COULTER, INC( DANAHER)
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
1. Illumina Inc.
2. Agilent Technologies, Inc.
3. Thermo Fisher Scientific Inc.
4. PerkinElmer, Inc.
5. QIAGEN
6. Abbott
7. BGI
8. F. Hoffmann La Roche AG
9. Bio Rad Laboratories, Inc.
10. Beckman Coulter, Inc(Danaher)
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For